MediLink Therapeutics

📍 Suzhou, China👥 46 employees💰 Last funded 2021
Biotechnology Research🌐 medilinkthera.com
Website LinkedIn
MediLink Therapeutics focuses on developing competitive drug conjugates internationally. With independent intellectual property rights, MediLink Therapeutics develops the next generation of conjugate technologies. The future products will provide better therapeutic windows for the unmet clinical needs. MediLink Therapeutics strives to upgrade technologies, establish diverse technology platforms for drug conjugates, and expand into new disease areas to serve global patients continuously.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in MediLink Therapeutics?
MediLink Therapeutics has 1 investors on record on gritt.io.
When did MediLink Therapeutics last raise funding?
The most recent investment in MediLink Therapeutics recorded on gritt.io was in 2021.
What industry is MediLink Therapeutics in?
MediLink Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is MediLink Therapeutics based?
MediLink Therapeutics is headquartered in Suzhou, China.